Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Arthritis Rheumatol. 2018 Jul 18;70(9):1470–1480. doi: 10.1002/art.40513

Table 3.

Treatment-emergent adverse events

Baminercept
N=33
 Placebo
N=19
Subjects, N (%) Events Subjects, N (%) Events
Total SAEs 5 (15) 5 1 (5) 1
Total AEs 33 (100) 356 19 (100) 204
Related to study drug 29 (88) 177 18 (95) 100
Severity (total AEs)*
 Grade 1 33 (100) 275 18 (95) 164
 Grade 2 25 (76) 70 13 (68) 36
 Grade 3 8 (24) 10 3 (16) 4
 Grade 4 1 (3) 1 0 (0) 0
 Grade 5 0 (0) 0 0 (0) 0

Abbreviations: SAE=serious adverse event; AE=adverse event;

*

graded using the Common Terminology Criteria for Adverse Events (CTCAE), version 4.0